Citation: | XU Liangyun, ZHANG Qigang, FAN Guanglai, ZHAO Jianhua. Establishment of fluorescent quantitative polymerase chain reaction detection method for human parvovirus B19[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 11-14, 20. DOI: 10.7619/jcmp.20210246 |
[1] |
PAVER W K, CAUL E O, CLARKE S K. Letter: Parvovirus-like particles in human sera[J]. Lancet, 1975, 1(7900): 232-232. http://europepmc.org/abstract/med/46024
|
[2] |
WALDMAN M, KOPP J B. Parvovirus B19 and the kidney[J]. Clin J Am Soc Nephrol, 2007, 2(Suppl 1): S47-S56. http://www.ncbi.nlm.nih.gov/pubmed/17699510
|
[3] |
KAHN J S, KESEBIR D, COTMORE S F, et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles[J]. J Infect Dis, 2008, 198(1): 41-50. doi: 10.1086/588674
|
[4] |
DE JONG E P, WALTHER F J, KROES A C M, et al. Parvovirus B19 infection in pregnancy: new insights and management[J]. Prenat Diagn, 2011, 31(5): 419-425. doi: 10.1002/pd.2714
|
[5] |
ROGO L D, MOKHTARI-AZAD T, KABIR M H, et al. Human parvovirus B19: a review[J]. Acta Virol, 2014, 58(3): 199-213. doi: 10.4149/av_2014_03_199
|
[6] |
罗青清, 骆名恋, 邹丽. "妊娠期微小病毒B19感染的临床实践指南"解读[J]. 中国实用妇科与产科杂志, 2016, 32(6): 502-504. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201606004.htm
|
[7] |
VALEUR-JENSEN A K, PEDERSEN C B, WESTERGAARD T, et al. Risk factors for parvovirus B19 infection in pregnancy[J]. JAMA, 1999, 281(12): 1099-1105. doi: 10.1001/jama.281.12.1099
|
[8] |
HARGER J H, ADLER S P, KOCH W C, et al. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms[J]. Obstet Gynecol, 1998, 91(3): 413-420. doi: 10.1016/S0029-7844(97)00701-1
|
[9] |
ZHOU Y, BIAN G H, ZHOU Q X, et al. Detection of cytomegalovirus, human parvovirus B19, and Herpes simplex virus-1/2 in women with first-trimester spontaneous abortions[J]. J Med Virol, 2015, 87(10): 1749-1753. doi: 10.1002/jmv.24218
|
[10] |
杨忠心, 何惠君, 代方, 等. 无偿献血员血清人微小病毒B19感染情况调查[J]. 华中科技大学学报: 医学版, 2003, 32(3): 344-345. doi: 10.3870/j.issn.1672-0741.2003.03.035
|
[11] |
JIA J T, MA Y Y, ZHAO X, et al. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives[J]. Virol J, 2015, 12: 162-162. doi: 10.1186/s12985-015-0396-z
|
[12] |
BREDL S, PLENTZ A, WENZEL J J, et al. False-negative serology in patients with acute parvovirus B19 infection[J]. J Clin Virol, 2011, 51(2): 115-120. doi: 10.1016/j.jcv.2011.03.012
|
[13] |
JIA J T, ZHONG Y D, GUO Y, et al. Simultaneous detection and differentiation of human parvovirus B19 and human parvovirus 4 by an internally controlled multiplex quantitative real-time PCR[J]. Mol Cell Probes, 2017, 36: 50-57. doi: 10.1016/j.mcp.2017.08.005
|
[14] |
ALVES A D R, CUBEL GARCIA R C N, CRUZ O G, et al. Quantitative real-time PCR for differential diagnostics of parvovirus B19 infection in acute liver failure patients[J]. Expert Rev Mol Diagn, 2019, 19(3): 259-266. doi: 10.1080/14737159.2019.1582333
|
[15] |
VON KIETZELL K, POZZUTO T, HEILBRONN R, et al. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q[J]. J Virol, 2014, 88(14): 8102-8115. doi: 10.1128/JVI.00649-14
|